PEIJIA-B Successfully Implants First Patient in U.S. Early Feasibility Study for GeminiOne® TEER System

Stock News
04/09

PeiJia Medical-B (09996) announced that the first patient implantation for the GeminiOne® transcatheter edge-to-edge repair (TEER) system in the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS) has been successfully completed. The procedure was performed by Professor Saibal Kar, Director of Structural Heart Intervention and Clinical Research at Los Robles Regional Medical Center, part of HCA Healthcare, and Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10